Developing a Preoperative Algorithm for the Diagnosis of Uterine Leiomyosarcoma.

Early diagnosis of the rare and life-threatening uterine leiomyosarcoma (LMS) is essential for prompt treatment, to improve survival. Preoperative distinction of LMS from benign leiomyoma remains a challenge, and thus LMS is often diagnosed post-operatively. This retrospective observational study evaluated the predictive diagnostic utility of 32 preoperative variables in 190 women who underwent a hysterectomy, with a postoperative diagnosis of leiomyoma ( = 159) or LMS ( = 31), at the Liverpool Women's National Health Service (NHS) Foundation Trust, between 2010 and 2019. A total of 7 preoperative variables were associated with increased odds of LMS, including postmenopausal status ( < 0.001, OR 3.08), symptoms of pressure ( = 0.002, OR 2.7), postmenopausal bleeding ( = 0.001, OR 5.01), neutrophil count ≥7.5 × 10/L ( < 0.001, OR 5.72), haemoglobin level <118 g/L ( = 0.037, OR 2.22), endometrial biopsy results of cellular atypia or neoplasia ( = 0.001, OR 9.6), and a mass size of ≥10 cm on radiological imaging ( < 0.0001, OR 8.52). This study has identified readily available and easily identifiable preoperative clinical variables that can be implemented into clinical practice to discern those with high risk of LMS, for further specialist investigations in women presenting with symptoms of leiomyoma.